ViTAA Medical announces FDA 510(k) clearance for aortic planning platform

ViTAA Medical today announced that the Food and Drug Administration (FDA) has granted 510(k) clearance for AiORTA Plan, which the company describes as a “fully automated, hyper-precise aortic surgery planning solution”. The tool aims to automate key preoperative measurements and…
Philips announces FDA approval for enhanced LumiGuide guidewire, marks 1000th patient treated with 3D guidance technology

Royal Philips today announced the introduction of the 160cm Food and Drug Administration (FDA)-approved version of its LumiGuide endovascular navigation wire. This enhanced LumiGuide guidewire, which utilises the company’s Fiber Optic RealShape (FORS) technology, was used for the first time…
Survey of off-label treatment of complex repair pinpoints factors behind underreported outcomes data

The potential for cost and time to be key factors in low levels of outcomes data reporting emerged during a national survey of the off-label use of approved endovascular devices for complex aortic aneurysm repair. Grayson S. Pitcher, MD, an…
New data on TAMBE outcomes in complex aortic aneurysms revealed

The US Food and Drug Administration (FDA)-approved Gore Excluder Thoracoabdominal Branch Endoprosthesis (TAMBE) has been shown to be safe and effective at 30 days for the treatment of patients with complex aortic aneurysms involving the visceral aorta. This is according…
The top 10 most popular Vascular Specialist stories of February 2024

In February, the most read stories from Vascular Specialist include a study of metformin and its potential as the first-ever medical treatment that can manage aneurysm disease; the SVS Sub-Section on Outpatient and Office Vascular Care (SOOVC) release the highly anticipated…
VAM 2023: Endovascular thermal septotomy for chronic post-dissection aortic aneurysm

Aidin Baghbani-Oskouei, MD, and Gustavo S. Oderich, MD, from the University of Texas Health Science Center at Houston, Texas, detail the endovascular thermal septotomy technique for chronic post-dissection thoracoabdominal aortic aneurysms (TAAAs), which featured as a video presentation at the…
How an aortic ally can help physicians optimize patient outcomes

This advertorial is sponsored by Gore. The aorta is special. As one of the most complex and critically important vessels of the vascular system, the aorta presents unique challenges. As such, it deserves an investment in constant and specialized care…
Medical therapy linked with low early mortality in type B aortic intramural hematoma patients

Medical management of type B aortic intramural hematomas is associated with low early mortality but a 19% risk of aortic-related intervention—primarily for proximal descending thoracic aneurysms, researchers from the Mayo Clinic in Rochester, Minnesota, found. The investigators report that elevated…
Endovascular aortic arch repair with three-vessel inner branches is safe, investigators find

Total endovascular aortic arch repair for aneurysms and chronic dissections using three-vessel inner branch stent-grafts is technically feasible and safe, a multicenter global early feasibility study finds. “Mortality and stroke rates compare favorably to reported outcomes of total open surgical…
‘Alarming rate’ of severe cerebrospinal fluid drain complications discovered in first-stage TEVAR and F-BEVAR of aortic aneurysm procedures

Severe complications from placement of cerebrospinal fluid drains (CSFD) during first-stage thoracic endovascular aortic repair (TEVAR) and fenestrated-branched endovascular repair (F-BEVAR) of pararenal and thoracoabdominal aortic aneurysms (TAAAs) were found to occur at an “alarming rate” in a prospective, nonrandomized…

